Neogen Chemicals Other Announcement

Neogen Chemicals Annual General Meeting

Neogen Chemicals seeks shareholder approval via postal ballot for related party transactions with a step-down subsidiary. E-voting runs until December 6, 2026.

Neogen Chemicals Earnings Call Transcript: Key Takeaways

Revenue rose 42% to ₹296 Cr and consolidated PAT rose 144% to ₹8 Cr, but a large standalone-to-consolidated gap shows the Neogen Ionics drag. Net debt is ₹1,095 Cr, and management gave no hard quarterly target to test against.

Neogen Chemicals Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.

Neogen Chemicals Results Update

Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.

Neogen Chemicals Debt & Borrowing: ₹500 Cr

Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.

Value

₹500.0 Cr

Neogen Chemicals Capacity Expansion: ₹45 Cr Investment

Neogen Chemicals' board approved a capacity addition of 600 MT/PA with a Rs 45.00 Crore investment. Funding will come from internal accruals and debt.

Value

₹45.00 Cr

Execution

By end of next financial year

manufacturing capacity

600.0 MTPA

One Point One Solutions Other Announcement

One Point One Solutions filed its quarterly shareholding pattern under Regulation 31(1)(c). It is a routine ownership disclosure with no transaction or capital event.

Mittal Sections Other Announcement

Mittal Sections filed CARE Ratings' IPO fund monitoring report for the quarter ended September 30, 2026. No deviation from IPO objects; ₹0.32 crore unutilised.

Mehul Colours Other Announcement

Mehul Colours disclosed utilisation of IPO proceeds up to 30 September 2026, with auditor certification. No deviation from the stated objects was reported.

Capricorn Systems Global Solutions Other Announcement

Capricorn Systems reports rights issue proceeds fully utilised as of September 30, 2026, with no deviation. This is a routine Regulation 32 utilisation statement.

Thrive Future Habitats Other Announcement

Thrive Future Habitats Ltd filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Note 1 records 93,12,364 shares allotted on warrant conversion, pending demat and lock-in.

Shelter Pharma Other Announcement

Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.